Global Thrombosis Drugs Market 2024-2028

Global Thrombosis Drugs Market 2024-2028


Thrombosis Drugs Market 2024-2028

The thrombosis drugs market is forecasted to grow by USD 17018.4 mn during 2023-2028, accelerating at a CAGR of 10.03% during the forecast period. The report on the thrombosis drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by introduction of novel oral anticoagulants, growing prevalence of coagulation disorders, and growing awareness of cardiac care.

Technavio's thrombosis drugs market is segmented as below:

By Indication
  • Pulmonary embolism
  • DVT
By Geographical Landscape
  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the sedentary lifestyle as one of the prime reasons driving the thrombosis drugs market growth during the next few years. Also, high prevalence of thrombosis and advent of anticoagulant antidotes will lead to sizable demand in the market.

The report on the thrombosis drugs market covers the following areas:
  • Thrombosis drugs market sizing
  • Thrombosis drugs market forecast
  • Thrombosis drugs market industry analysis
The vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading thrombosis drugs market vendors that include Aspen Pharmacare Holdings Ltd., AuroMedics Pharma LLC, Baxter International Inc., Bayer AG, Biogen Inc., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., F. Hoffmann La Roche Ltd., GlaxoSmithKline PLC, GoodRx Holdings Inc., Grifols SA, Inari Medical Inc., Italfarmaco Holding SPA, Johnson and Johnson Services Inc., Pfizer Inc., Sanofi SA, Vasudha Pharma Chem Ltd., and Viatris Inc.. Also, the thrombosis drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The companies presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.


1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Indication
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Thrombosis Drugs Market 2018 - 2022
Historic Market Size - Data Table on Global Thrombosis Drugs Market 2018 - 2022 ($ million)
4.2 Indication segment analysis 2018 - 2022
Historic Market Size - Indication Segment 2018 - 2022 ($ million)
4.3 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.4 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Indication
6.1 Market segments
Chart on Indication - Market share 2023-2028 (%)
Data Table on Indication - Market share 2023-2028 (%)
6.2 Comparison by Indication
Chart on Comparison by Indication
Data Table on Comparison by Indication
6.3 Pulmonary embolism - Market size and forecast 2023-2028
Chart on Pulmonary embolism - Market size and forecast 2023-2028 ($ million)
Data Table on Pulmonary embolism - Market size and forecast 2023-2028 ($ million)
Chart on Pulmonary embolism - Year-over-year growth 2023-2028 (%)
Data Table on Pulmonary embolism - Year-over-year growth 2023-2028 (%)
6.4 DVT - Market size and forecast 2023-2028
Chart on DVT - Market size and forecast 2023-2028 ($ million)
Data Table on DVT - Market size and forecast 2023-2028 ($ million)
Chart on DVT - Year-over-year growth 2023-2028 (%)
Data Table on DVT - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Indication
Market opportunity by Indication ($ million)
Data Table on Market opportunity by Indication ($ million)
7 Customer Landscape
7.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape
8.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
8.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
8.8 France - Market size and forecast 2023-2028
Chart on France - Market size and forecast 2023-2028 ($ million)
Data Table on France - Market size and forecast 2023-2028 ($ million)
Chart on France - Year-over-year growth 2023-2028 (%)
Data Table on France - Year-over-year growth 2023-2028 (%)
8.9 Norway - Market size and forecast 2023-2028
Chart on Norway - Market size and forecast 2023-2028 ($ million)
Data Table on Norway - Market size and forecast 2023-2028 ($ million)
Chart on Norway - Year-over-year growth 2023-2028 (%)
Data Table on Norway - Year-over-year growth 2023-2028 (%)
8.10 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
8.11 Japan - Market size and forecast 2023-2028
Chart on Japan - Market size and forecast 2023-2028 ($ million)
Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Chart on Japan - Year-over-year growth 2023-2028 (%)
Data Table on Japan - Year-over-year growth 2023-2028 (%)
8.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
9 Drivers, Challenges, and Opportunity/Restraints
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints
10 Competitive Landscape
10.1 Overview
10.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
Overview on factors of disruption
10.4 Industry risks
Impact of key risks on business
11 Competitive Analysis
11.1 Companies profiled
Companies covered
11.2 Market positioning of companies
Matrix on companies position and classification
11.3 Aspen Pharmacare Holdings Ltd.
Aspen Pharmacare Holdings Ltd. - Overview
Aspen Pharmacare Holdings Ltd. - Business segments
Aspen Pharmacare Holdings Ltd. - Key offerings
Aspen Pharmacare Holdings Ltd. - Segment focus
11.4 Baxter International Inc.
Baxter International Inc. - Overview
Baxter International Inc. - Business segments
Baxter International Inc. - Key news
Baxter International Inc. - Key offerings
Baxter International Inc. - Segment focus
11.5 Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH - Overview
Boehringer Ingelheim International GmbH - Product / Service
Boehringer Ingelheim International GmbH - Key news
Boehringer Ingelheim International GmbH - Key offerings
11.6 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
11.7 Daiichi Sankyo Co. Ltd.
Daiichi Sankyo Co. Ltd. - Overview
Daiichi Sankyo Co. Ltd. - Product / Service
Daiichi Sankyo Co. Ltd. - Key news
Daiichi Sankyo Co. Ltd. - Key offerings
11.8 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
11.9 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
11.10 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
11.11 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
11.12 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
12.3 Currency conversion rates for US$
Currency conversion rates for US$
12.4 Research methodology
Research methodology
12.5 Data procurement
Information sources
12.6 Data validation
Data validation
12.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
12.8 Data synthesis
Data synthesis
12.9 360 degree market analysis
360 degree market analysis
12.10 List of abbreviations
List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Indication
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Company Market Positioning
Exhibits9: Parent Market
Exhibits10: Data Table on - Parent Market
Exhibits11: Market characteristics analysis
Exhibits12: Value Chain Analysis
Exhibits13: Offerings of companies included in the market definition
Exhibits14: Market segments
Exhibits15: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Historic Market Size - Data Table on Global Thrombosis Drugs Market 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Indication Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Indication - Market share 2023-2028 (%)
Exhibits31: Data Table on Indication - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Indication
Exhibits33: Data Table on Comparison by Indication
Exhibits34: Chart on Pulmonary embolism - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Pulmonary embolism - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Pulmonary embolism - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Pulmonary embolism - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on DVT - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on DVT - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on DVT - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on DVT - Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Indication ($ million)
Exhibits43: Data Table on Market opportunity by Indication ($ million)
Exhibits44: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits45: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits46: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits47: Chart on Geographic comparison
Exhibits48: Data Table on Geographic comparison
Exhibits49: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits50: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits51: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits52: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits53: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits54: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits55: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits56: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits57: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits58: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits59: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits60: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits61: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits62: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits63: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits64: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits65: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits66: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits67: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits68: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits69: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on Norway - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on Norway - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on Norway - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on Norway - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits85: Market opportunity By Geographical Landscape ($ million)
Exhibits86: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits87: Impact of drivers and challenges in 2023 and 2028
Exhibits88: Overview on criticality of inputs and factors of differentiation
Exhibits89: Overview on factors of disruption
Exhibits90: Impact of key risks on business
Exhibits91: Companies covered
Exhibits92: Matrix on companies position and classification
Exhibits93: Aspen Pharmacare Holdings Ltd. - Overview
Exhibits94: Aspen Pharmacare Holdings Ltd. - Business segments
Exhibits95: Aspen Pharmacare Holdings Ltd. - Key offerings
Exhibits96: Aspen Pharmacare Holdings Ltd. - Segment focus
Exhibits97: Baxter International Inc. - Overview
Exhibits98: Baxter International Inc. - Business segments
Exhibits99: Baxter International Inc. - Key news
Exhibits100: Baxter International Inc. - Key offerings
Exhibits101: Baxter International Inc. - Segment focus
Exhibits102: Boehringer Ingelheim International GmbH - Overview
Exhibits103: Boehringer Ingelheim International GmbH - Product / Service
Exhibits104: Boehringer Ingelheim International GmbH - Key news
Exhibits105: Boehringer Ingelheim International GmbH - Key offerings
Exhibits106: Bristol Myers Squibb Co. - Overview
Exhibits107: Bristol Myers Squibb Co. - Product / Service
Exhibits108: Bristol Myers Squibb Co. - Key news
Exhibits109: Bristol Myers Squibb Co. - Key offerings
Exhibits110: Daiichi Sankyo Co. Ltd. - Overview
Exhibits111: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibits112: Daiichi Sankyo Co. Ltd. - Key news
Exhibits113: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits114: F. Hoffmann La Roche Ltd. - Overview
Exhibits115: F. Hoffmann La Roche Ltd. - Business segments
Exhibits116: F. Hoffmann La Roche Ltd. - Key news
Exhibits117: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits118: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits119: GlaxoSmithKline Plc - Overview
Exhibits120: GlaxoSmithKline Plc - Business segments
Exhibits121: GlaxoSmithKline Plc - Key news
Exhibits122: GlaxoSmithKline Plc - Key offerings
Exhibits123: GlaxoSmithKline Plc - Segment focus
Exhibits124: Johnson and Johnson Services Inc. - Overview
Exhibits125: Johnson and Johnson Services Inc. - Business segments
Exhibits126: Johnson and Johnson Services Inc. - Key news
Exhibits127: Johnson and Johnson Services Inc. - Key offerings
Exhibits128: Johnson and Johnson Services Inc. - Segment focus
Exhibits129: Pfizer Inc. - Overview
Exhibits130: Pfizer Inc. - Product / Service
Exhibits131: Pfizer Inc. - Key news
Exhibits132: Pfizer Inc. - Key offerings
Exhibits133: Sanofi SA - Overview
Exhibits134: Sanofi SA - Business segments
Exhibits135: Sanofi SA - Key news
Exhibits136: Sanofi SA - Key offerings
Exhibits137: Sanofi SA - Segment focus
Exhibits138: Inclusions checklist
Exhibits139: Exclusions checklist
Exhibits140: Currency conversion rates for US$
Exhibits141: Research methodology
Exhibits142: Information sources
Exhibits143: Data validation
Exhibits144: Validation techniques employed for market sizing
Exhibits145: Data synthesis
Exhibits146: 360 degree market analysis
Exhibits147: List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings